Our knowledge of the genetics of the complement system stems from two types of information: the detection of genetic markers on complement components and the study of isolated component deficiency states in man and animals. Since there are a substantial number of complement components, the potential data yield of such studies is considerable. The Allotypy of complement components C3. C3 is both in amount and in biological importance the major complement component. It is also the first in which the existence of population polymorphism was described (at the 1st International Symposium and Workshop; see Vox Sanguinis, 1973) . For all these reasons, this is the allotype system that has been most extensively studied. The C3 allotypes are distinguished by their electrophoretic mobility. The two major allotypes were described as fast (gene frequency in Caucasions 0.25) and slow (gene frequency in Caucasions 0.75) and a variety of rare allotypes with different mobility also occur. The C3 allotypes do not appear to be functionally different but it has recently been claimed that C3f is better at producing rosettes with macrophages than is C3s (Arvilommi, 1974) . Mendelian inheritance of the allotypes within families is readily shown.
The other allotypic systems have so far been studied less.
Factor B. Factor B shows electrophoretically detectable allotypes in a similar way to C3 (Hobart et al, 1975 Population heterogeneity. The combination of isoelectric focusing, which has very high resolving power, and specific functional detection, promises to be a powerful tool for the investigation of complement polymorphisms. It shows complex banding patterns for all components that have so far been studied and has so far revealed population heterogeneity in C2 and factor D. It can be used as an alternative method for the detection of factor B polymorphism.
Population heterogeneity has also been reported in C4 (Rosenfeld et al, 1969) but it is not inherited in a clearly Mendelian pattern and its significance is still not clear. Since this technique for detecting polymorphism is highly discriminating and rapid to perform it is to be envisaged that the study of complement allotypes will rapidly expand.
Linkage. A major interest of this work is to establish whether there is linkage between the markers on different complement components and in this way to see whether information can be obtained about the evolution of complement. This interest became much more intense when it was found that Factor B showed close linkage to the HL-A locus in man (Allen, 1974 ) since this locus is intimately concerned with immunological phenomena. In general, proteins coded at or around the HL-A locus are present on cell membranes and it may be relevant that an activity resembling Factor B has been found on lymphocyte membranes (Halbwachs, McConnell, and Lachmann, 1975) .
Further associations between complement and the principal transplantation locus of various species have recently come to light.
In man the 'C2-deficiency gene' (q.v.) is linked to HL-A and appears to show a particular association with the haplotype 10, W18 (Fu et al, 1974) . The significance of this linkage disequilibrium is obscure. However, a similar phenomenon has been reported in the guinea pig where the 'C4 deficiency gene' is associated with the B allele of the principal histocompatibility locus (Shevach, Frank, and Green, 1975) . In the only known C4 deficient human family the C4 deficiency gene has been reported to be linked to the HL-A haplotype 2-T3-W10 for which the propositus is homozygous. In these cases it is not yet firmly established that it is the structural gene that is involved, though in the case of C2 it seems particularly likely since C2 and Factor B are homologues in the classical and alternative pathways and it is attractive to think they may be the products of duplicated genes.
In the mouse the Ss-Slp protein is coded in the H2 region and there is evidence that this may be a complement component (Demant et al, 1973) . It seems to be C4 . C3 levels in mice are also controlled by a gene linked to H2 and at least one other not so linked (Ferrara and Nussenzweig, 1975) (Lerner et al, 1972) ; mycoplasma in the case of HenochSch6nlein purpura and possibly a variety of viral infections in the case of glomerulorephritis. It therefore seems possible that deficiencies at this stage of the complement system may predispose to infection with organisms whose virulence is low and which give rise to diseases of allergic pathogenesis, particularly immune complex disease. Nevertheless C4-deficient guinea pigs kept in laboratory conditions appear to be quite healthy.
Group 3 includes patients deficient in C5 (two cases), C6 (two cases), and C7 (two cases). One of the C5-deficient cases has systemic LE while the other is healthy. The two C6-deficient patients seem to have no diseases relevant to their complement deficiency and this is probably also true of the two C7-deficient cases. In a similar way, the C5-deficient mice and the C6-deficient rabbits kept under laboratory conditions appear to be quite healthy. Although it remains to be seen whether an increased incidence of systemic LE exists among patients with deficiencies of C5, C6, and C7 it would seem at the present time that deficiencies of this stage of the complement sequence are relatively well tolerated. In fact in the C6-deficient rabbit it is possible to discern a potential advantage in their deficiency as these animals are relatively resistant to endotoxin shock (Brown and Lachmann, 1973) which produces death in the rabbit as a result of complement activation and disseminated intravascular coagulation resulting from it.
Group 4 included the patients with hereditary angioedema associated with deficiency of the CTinhibitor. This deficiency is unique among the complement deficiencies in that it is the heterozygote that develops the disease which is therefore transmitted as an autosomal dominant. The CTinhibitor or a2 neuraminoglycoprotein is an important inhibitor not only of C1 but of a number of other plasma esterases including plasmin, kallikrein, and factors Xla and Xlla of the coagulation system. However, it is the complement system that appears to be important in the pathogenesis of the angioedema since the C2-deficient subject will not give a wheal and flare on injection of CT. In the absence of the inhibitor the unrestrained action of CT or C4 a:d C2 in the fluid phase produces a 'kinin-like' fragment which seems to be the main mediator of the disease (Donaldson et al, 1970) . The characteristic attacks of the disease appear to be brought about by the exhaustion of the small amount of inhibitor available at an extravascular site, probably as a result of the activation of any of the enzymes with which it reacts. This is followed by the (pseudo) autocatalytic activation of CT and the destruction of C4 and C2. Attacks of the disease have been successfully treated by giving fresh plasma containing the missing inhibitor (Pickering et al, 1969) and prevented by the long-term administration of epsilon amino-caproic acid or its analogues which prevent the activation of the whole range of enzymes with which C1-inhibitor reacts and thus exert an 'inhibitor sparing' effect (Hadjiyannaki and Lachmann, 1971 (Azar et al, 1968; Dukor and Hartmann, 1973) .
